Vireo Growth Inc. and C21 Investments Inc. Announce Definitive Arrangement Agreement
C21 Agrees to All-Stock Sale to Vireo Growth; Shareholders Swap Nevada Pure-Play for Vireo Paper at Unclear Premium
- Vireo Growth Inc. will acquire 100% of C21 Investments in a stock-for-stock transaction via a court-approved plan of arrangement.
- Exchange ratio: each C21 shareholder will receive 0.023052 of a Vireo subordinate voting share per C21 share.
- Combined Nevada presence: ~15 dispensaries and 158,000 sq ft of cultivation/manufacturing capacity; adds Silver State Relief brand.
- Required approvals: 2/3 vote of C21 shareholders, BC court approval, regulatory clearances; shareholder meeting expected Q3 2026.
- C21 directors and officers have signed voting support agreements; C21 to be delisted from the CSE and OTCQX post-closing.
- Termination fee of $3M payable by C21 in certain circumstances; deal includes non-solicit, fiduciary out, and right-to-match provisions.
- Needham & Company provided a fairness opinion to C21.
This is a definitive takeover that will eliminate C21 as a standalone entity. The announcement is genuinely new and transformative; however, the value received by C21 shareholders is opaque. The exchange ratio is fixed, but Vireo’s share price is not in the provided data, so the implied premium (or discount) cannot be calculated. A stock that had been battered by 280E uncertainty and a going‑concern flag offers shareholders liquidity via Vireo equity, but that equity itself may be illiquid and carries the same tax risk. The $13.4M uncertain tax liability simply transfers to the acquirer — a substantial contingent claim that could dilute the combined entity. On balance, the acquisition re‑rates C21’s equity from a standalone distressed micro‑cap to a contingent claim on a larger platform, but the lack of a cash floor means the outcome is uncertain. The Material – Game Changer rating is appropriate because the corporate structure and risk profile change fundamentally, but the ultimate economic upside hinges on Vireo’s valuation and the tax outcome.
C21 Investments Inc. is a U.S. cannabis operator primarily focused on Nevada, with cultivation, manufacturing, and retail operations under the Silver State Relief brand. It operated three dispensaries and generated $32.6M in FY2026 revenue from a record 725,000 customer transactions. Oregon operations have been discontinued since early 2022. The company is listed on the Canadian Securities Exchange and trades on the OTCQX.